Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Ahmad, Sarfaraz ^a   Varagic, Jasmina ^a   Westwood, Brian M ^a   Chappell, Mark C ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN (1-12); ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IODINE 125; MEMBRANE METALLOENDOPEPTIDASE; UNCLASSIFIED DRUG; ANGIOTENSIN (1 12), RAT; ANGIOTENSIN (1-12), RAT; ANGIOTENSIN DERIVATIVE; PEPTIDE FRAGMENT; RADIOACTIVE IODINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEART CELL CULTURE; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN HYDROLYSIS; PROTEIN METABOLISM; PROTEIN TRANSPORT; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; ANIMAL; COMPARATIVE STUDY; ENZYME SPECIFICITY; HYDROLYSIS; METABOLISM;

RATTUS;

ANGIOTENSINS; ANIMALS; ANIMALS, NEWBORN; HYDROLYSIS; IODINE RADIOISOTOPES; METABOLIC NETWORKS AND PATHWAYS; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUBSTRATE SPECIFICITY;

EID: 79251592234     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015759     Document Type: Article

References (37)

1. Nagata S, Kato J, Sasaki K, Minamino N, Eto T, et al. (2006) Isolation and identification of proangiotensin-12, a possible component of the reninangiotensin system. Biochem Biophys Res Commun 350: 1026-1031.
2. Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Goodfriend T, et al. (1991) Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension 17: 720-721.
3. Jessup JA, Trask AJ, Chappell MC, Nagata S, Kato J, et al. (2008) Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 294: H2614-H2618.
4. Trask AJ, Jessup JA, Chappell MC, Ferrario CM (2008) Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart. Am J Physiol Heart Circ Physiol - 294: H2242-H2247. 00175.2008.
5. Ferrario CM, Varagic J, Habibi J, Nagata S, Kato J, et al. (2009) Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy. Am J Physiol Heart Circ Physiol 296: H1184-H1192+01114+2008.
6. Ichihara A (2009) [Development of hypertension and RAAS]. Nippon Jinzo Gakkai Shi 51: 433-437.
7. Nagata S, Kato J, Kuwasako K, Kitamura K (2010) Plasma and tissue levels of proangiotensin-12 and components of the renin-angiotensin system (RAS) following low- or high-salt feeding in rats. Peptides 31: 889-892.
8. Prosser HC, Forster ME, Richards AM, Pemberton CJ (2009) Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics. Cardiovasc Res 82: 40-50.
9. Ahmad S, Varagic J, Westwood BM, Chappell MC, Strawn WB, et al. (2010) Chymase-dependent generation of Angiotensin II from Angiotensin-(1-12) in human atrial tissue. FASEB J 24: 605.4.
10. Guo C, Ju H, Leung D, Massaeli H, Shi M, et al. (2001) A novel vascular smooth muscle chymase is upregulated in hypertensive rats. J Clin Invest 107: 703-715.
11. Engelmann GL, Gerrity RG (1988) Biochemical characterization of neonatal cardiomyocyte development in normotensive and hypertensive rats. J Mol Cell Cardiol 20: 169-177.
12. Clubb FJ, Jr., Bell PD, Kriseman JD, Bishop SP (1987) Myocardial cell growth and blood pressure development in neonatal spontaneously hypertensive rats. Lab Invest 56: 189-197.
13. Axelband F, Dias J, Miranda F, Ferrao FM, Barros NM, et al. (2009) A scrutiny of the biochemical pathways from Ang II to Ang-(3-4) in renal basolateral membranes. Regul Pept 158: 47-56.
14. Bauer J, Berthold H, Schaefer F, Ehmke H, Parekh N (1999) Quantification of conversion and degradation of circulating angiotensin in rats. Am J Physiol 277: R412-R418.
15. Cernucan DL, Gurzu B, Slatineanu S, Dumitriu IL, Slatineanu SM, et al. (2007) Contractile effects of angiotensinogen and its multiple metabolization pathways on vessel walls. Rev Med Chir Soc Med Nat Iasi 111: 717-721.
16. Danser AH, Schalekamp MA (1996) Is there an internal cardiac reninangiotensin system? Heart 76: 28-32.
17. Danser AH (1996) Local renin-angiotensin systems. Mol Cell Biochem 157: 211-216.
18. Re RN, Cook JL (2006) The intracrine hypothesis: an update. Regul Pept 133: 1-9.
19. van Kats JP, Danser AH, van Meegen JR, Sassen LM, Verdouw PD, et al. (1998) Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 98: 73-81.
20. Singh VP, Le B, Khode R, Baker KM, Kumar R (2008) Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57: 3297-3306.
21. Sano H, Okamoto H, Kitabatake A, Iizuka K, Murakami T, et al. (1998) Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats. Mol Cell Biochem 178: 51-58.
22. Suzuki J, Matsubara H, Urakami M, Inada M (1993) Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 73: 439-447.
23. Matsushima Y, Kawamura M, Akabane S, Imanishi M, Kuramochi M, et al. (1988) Increases in renal angiotensin II content and tubular angiotensin II receptors in prehypertensive spontaneously hypertensive rats. J Hypertens 6: 791-796.
24. Kuzuo H, Honda M, Tanaka K, Kuramochi T, Morioka S, et al. (1995) Direct effects of angiotensin I, angiotensin II, an ACE inhibitor and a serine proteinase inhibitor on cultured heart cells from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22: 82-86.
25. Pan N, Luo J, Kaiser SJ, Frome WL, Dart RA, et al. (2006) Specific receptor for angiotensinogen on human renal cells. Clin Chim Acta 373: 32-36.
26. Yayama K, Yoshiya M, Takahashi K, Matsui T, Takano M, et al. (1995) Role of the kidney in the plasma clearance of angiotensinogen in the rat: plasma clearance and tissue distribution of 125I-angiotensinogen. Life Sci 57: 1791-1801.
27. Mineo C, Yagyu Y, Imanaka T, Takano T (1990) Transcellular transport of angiotensin II through a cultured arterial endothelial monolayer. Exp Cell Res 190: 99-103.
28. Yamada S, Honda M, Morioka S, Ohoka M, Yamori Y, et al. (1989) Study of the pathogenesis of cardiac hypertrophy-biochemical differences of cultured heart cells from normotensive and spontaneously hypertensive rats. Jpn Circ J 53: 1221-1228.
29. Wei CC, Tian B, Perry G, Meng QC, Chen YF, Oparil S, et al. (2002) Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene. Am J Physiol Heart Circ Physiol 282: H2254-H2258.
30. Wei CC, Hase N, Inoue Y, Bradley EW, Yahiro E, et al. (2010) Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents. J Clin Invest 120: 1229-1239.
31. Ferrario CM (2010) New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism. Hypertension 55: 445-452.
32. Kirimura K, Takai S, Jin D, Muramatsu M, Kishi K, et al. (2005) Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats. Hypertens Res 28: 457-464.
33. Tallant EA, Clark MA (2003) Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7). Hypertension 42: 574-579.
34. Tallant EA, Ferrario CM, Gallagher PE (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 289: H1560-H1566.
35. Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, et al. (2007) Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol 292: F82-F91.
36. Shaltout HA, Figueroa JP, Rose JC, Diz DI, Chappell MC (2009) Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension. Hypertension 53: 404-408.
37. Cohen JA, Lindsey SH, Pirro NT, Brosnihan KB, Gallagher PE, et al. (2010) Influence of estrogen depletion and salt loading on renal angiotensinogen expression in the mRen(2).Lewis strain. Am J Physiol Renal Physiol 299: F35-F42.